Baidu
map

Chest:暴露于电子尼古丁传递系统二手气溶胶与哮喘患者急性发作

2018-10-23 xing.T MedSci原创

由此可见,二手ENDS气溶胶暴露可能与青少年的哮喘症状有关。医生可能需要就哮喘暴露的潜在风险向哮喘青年提供咨询。未来的研究需要进一步评估二手ENDS气溶胶暴露与哮喘控制之间的纵向关系。

目前的研究表明电子尼古丁传递系统(ENDS)与年轻人的哮喘症状有关,但对二手ENDS气溶胶暴露与哮喘控制之间的关联知之甚少。近日,呼吸领域权威杂志chest上发表了一篇研究文章,该研究探讨了二手ENDS气溶胶暴露与青年哮喘患者急性发作之间的关系。

参加了2016年佛罗里达州青少年烟草调查(年龄11-17岁)且自我报告的哮喘诊断(11830)的青少年报告了过去12个月的哮喘发作、人口统计学指标、吸烟、吸雪茄、吸水烟、ENDS使用、过去30天的二手烟暴露以及过去30天的二手ENDS气溶胶暴露。加权多变量Logistic回归模型用于评估二手ENDS气溶胶暴露与过去12个月哮喘发作状态之间的关联,并调整了协变量。

总体而言,21%的哮喘青年报告在过去12个月内发生了哮喘发作,33%报告曾暴露于二手ENDS气溶胶。二手ENDS气溶胶暴露与过去12个月报告哮喘发作的几率相关,调整协变量后(AOR为1.27,95%CI为1.11-1.47)。

由此可见,二手ENDS气溶胶暴露可能与青少年的哮喘症状有关。医生可能需要就哮喘暴露的潜在风险向哮喘青年提供咨询。未来的研究需要进一步评估二手ENDS气溶胶暴露与哮喘控制之间的纵向关系。

原始出处:


Jennifer E. Bayly,et al. Secondhand exposure to aerosols from electronic nicotine delivery systems and asthma exacerbations among youth with asthma.chest.2018. https://doi.org/10.1016/j.chest.2018.10.005

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1929524, encodeId=0b4d19295247e, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Nov 05 22:55:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797847, encodeId=4bcb1e97847c6, content=<a href='/topic/show?id=a46423925ba' target=_blank style='color:#2F92EE;'>#二手气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23925, encryptionId=a46423925ba, topicName=二手气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Thu Jun 20 15:55:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051266, encodeId=9ebd2051266a6, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 11 08:55:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350657, encodeId=575035065e68, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sat Oct 27 15:14:36 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517655, encodeId=9741151e6558e, content=<a href='/topic/show?id=af406381462' target=_blank style='color:#2F92EE;'>#气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63814, encryptionId=af406381462, topicName=气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554308, encodeId=836a1554308bc, content=<a href='/topic/show?id=8402522319e' target=_blank style='color:#2F92EE;'>#急性发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52231, encryptionId=8402522319e, topicName=急性发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287314518946, createdName=anminleiryan, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=)]
    2018-11-05 Smile2680
  2. [GetPortalCommentsPageByObjectIdResponse(id=1929524, encodeId=0b4d19295247e, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Nov 05 22:55:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797847, encodeId=4bcb1e97847c6, content=<a href='/topic/show?id=a46423925ba' target=_blank style='color:#2F92EE;'>#二手气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23925, encryptionId=a46423925ba, topicName=二手气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Thu Jun 20 15:55:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051266, encodeId=9ebd2051266a6, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 11 08:55:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350657, encodeId=575035065e68, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sat Oct 27 15:14:36 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517655, encodeId=9741151e6558e, content=<a href='/topic/show?id=af406381462' target=_blank style='color:#2F92EE;'>#气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63814, encryptionId=af406381462, topicName=气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554308, encodeId=836a1554308bc, content=<a href='/topic/show?id=8402522319e' target=_blank style='color:#2F92EE;'>#急性发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52231, encryptionId=8402522319e, topicName=急性发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287314518946, createdName=anminleiryan, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1929524, encodeId=0b4d19295247e, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Nov 05 22:55:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797847, encodeId=4bcb1e97847c6, content=<a href='/topic/show?id=a46423925ba' target=_blank style='color:#2F92EE;'>#二手气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23925, encryptionId=a46423925ba, topicName=二手气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Thu Jun 20 15:55:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051266, encodeId=9ebd2051266a6, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 11 08:55:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350657, encodeId=575035065e68, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sat Oct 27 15:14:36 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517655, encodeId=9741151e6558e, content=<a href='/topic/show?id=af406381462' target=_blank style='color:#2F92EE;'>#气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63814, encryptionId=af406381462, topicName=气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554308, encodeId=836a1554308bc, content=<a href='/topic/show?id=8402522319e' target=_blank style='color:#2F92EE;'>#急性发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52231, encryptionId=8402522319e, topicName=急性发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287314518946, createdName=anminleiryan, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1929524, encodeId=0b4d19295247e, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Nov 05 22:55:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797847, encodeId=4bcb1e97847c6, content=<a href='/topic/show?id=a46423925ba' target=_blank style='color:#2F92EE;'>#二手气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23925, encryptionId=a46423925ba, topicName=二手气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Thu Jun 20 15:55:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051266, encodeId=9ebd2051266a6, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 11 08:55:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350657, encodeId=575035065e68, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sat Oct 27 15:14:36 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517655, encodeId=9741151e6558e, content=<a href='/topic/show?id=af406381462' target=_blank style='color:#2F92EE;'>#气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63814, encryptionId=af406381462, topicName=气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554308, encodeId=836a1554308bc, content=<a href='/topic/show?id=8402522319e' target=_blank style='color:#2F92EE;'>#急性发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52231, encryptionId=8402522319e, topicName=急性发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287314518946, createdName=anminleiryan, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=)]
    2018-10-27 orangesking

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1929524, encodeId=0b4d19295247e, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Nov 05 22:55:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797847, encodeId=4bcb1e97847c6, content=<a href='/topic/show?id=a46423925ba' target=_blank style='color:#2F92EE;'>#二手气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23925, encryptionId=a46423925ba, topicName=二手气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Thu Jun 20 15:55:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051266, encodeId=9ebd2051266a6, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 11 08:55:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350657, encodeId=575035065e68, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sat Oct 27 15:14:36 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517655, encodeId=9741151e6558e, content=<a href='/topic/show?id=af406381462' target=_blank style='color:#2F92EE;'>#气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63814, encryptionId=af406381462, topicName=气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554308, encodeId=836a1554308bc, content=<a href='/topic/show?id=8402522319e' target=_blank style='color:#2F92EE;'>#急性发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52231, encryptionId=8402522319e, topicName=急性发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287314518946, createdName=anminleiryan, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1929524, encodeId=0b4d19295247e, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Nov 05 22:55:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797847, encodeId=4bcb1e97847c6, content=<a href='/topic/show?id=a46423925ba' target=_blank style='color:#2F92EE;'>#二手气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23925, encryptionId=a46423925ba, topicName=二手气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Thu Jun 20 15:55:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051266, encodeId=9ebd2051266a6, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 11 08:55:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350657, encodeId=575035065e68, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Sat Oct 27 15:14:36 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517655, encodeId=9741151e6558e, content=<a href='/topic/show?id=af406381462' target=_blank style='color:#2F92EE;'>#气溶胶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63814, encryptionId=af406381462, topicName=气溶胶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554308, encodeId=836a1554308bc, content=<a href='/topic/show?id=8402522319e' target=_blank style='color:#2F92EE;'>#急性发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52231, encryptionId=8402522319e, topicName=急性发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287314518946, createdName=anminleiryan, createdTime=Wed Oct 24 23:55:00 CST 2018, time=2018-10-24, status=1, ipAttribution=)]

相关资讯

Diabetes Obes Metab:早年生活抗生素暴露与儿童超重和肥胖!

总之,婴儿期接受抗生素治疗与儿童超重和肥胖风险略有增加有关,主要是儿童在生命的头六个月内是否接受抗生素治疗以及是否接受重复治疗。这种相关性是否是抗生素通过对肠道微生物群的直接作用来介导仍然是不明确的。

JAHA:电生理手术对患者的辐射暴露问题不容忽视!

本研究的目的旨在大样本病人数据中评估电生理或器械植入术中X线暴露的情况和比较不同技术的房颤消融术对患者的X线暴露情况。本研究纳入了6095例接受电生理检查的患者和2055例器械植入的患者,经过7年时间的分析评估,发现电生理检查的X线暴露量、剂量面积乘积与有效剂量呈逐年下降趋势(p<0.001),通过分析2416例房颤消融术,发现7名不同的有经验的操作者在X线暴露量、剂量面积乘积与有效剂量方面存在明

Am J Resp Crit Care:长期较粗PM暴露与儿童哮喘相关!

在接受医疗补助计划的儿童中,暴露于较高水平的粗PM与哮喘患病率和发病率增加有关。这些结果表明,需要直接监测粗PM,并且重新审议长期平均较粗PM污染水平的限制标准。

J Hosp Infect:安全注射装置是否能减少针刺伤?

针刺伤是医疗机构血源性病原体传播的危险因素之一,对职业安全和患者安全带来双向的挑战。据估算,全球每年约有200万与HBV、HCV、HIV暴露相关的针刺伤发生,平均发生率约为3.7例次/100名医务人员。

J Am Acad Child:产前SSRI暴露是否影响学龄前儿童行为、情感和社会发育?

2018年3月,发表在《J Am Acad Child Adolesc Psychiatry》的一项由挪威科学家进行的研究,考察了妊娠期使用时间依赖的选择性5-羟色胺再摄取抑制剂(SSRI)抗抑郁药对学龄前儿童行为、情感和社会发育的影响。

JAMA Pediatr:妊娠期暴露于己烯雌酚 后代罹患神经发育缺陷风险累积增高?

发表在《JAMA Pediatr》的一项由美国和爱尔兰学者进行的研究,考察了妊娠期暴露于己烯雌酚与多代神经发育缺陷之间的相关性。

Baidu
map
Baidu
map
Baidu
map